The purpose of this research study titled ‘Diabetes Injection Pens Market - Growth, Future Prospects, and Competitive Analysis, 2022 - 2030’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global diabetes injection pens market. This report presents and analyzes the major trends prevalent in the global diabetes injection pens market and the market size and forecast.
This report categorizes the global diabetes injection pens market in terms of Diabetes type, product type, form and geographical distribution. Based on diabetes type, the global diabetes injection pens market is categorized into type I and type II diabetes. Insulin pens and insulin pen needles are the major product types considered in this study. Furthermore, disposable and reusable forms of diabetes injection pens are also studies in this report. Market size and forecast for each mentioned segment for the period 2020-2030 is presented in the report along with respective CAGRs for the forecast duration 2022-2030.
The market size and forecast of each considered geographical market is presented for the period 2020-2030 along with CAGRs for the forecast period 2022-2030 in this study and are further cross-sectional presented in terms of diabetes type, product type, form, and constituent region/country level markets.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global diabetes injection pens market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the diabetes injection pens market. The key players profiled in this report are AstraZeneca plc, Becton, Dickinson and Company, Biocon Ltd., Eli Lilly and Company, Jiangsu Delfu Co., Novo Nordisk A/S, Owen Mumford Ltd. and Wockhardt Ltd.
Injection pens are observed to be administered in both type I and type II patients. Between these patient groups, type II diabetes acquires the larger revenue share due to large patient population belonging to this condition. In addition, since type II diabetes majorly occurs in adult individuals, rational insulin administration through injection pens is highly prevalent. However, increasing patient base of children suffering with type II diabetes presents lucrative penetration opportunity to the diabetes injection pens manufacturers. Based on injection forms, this market is categorized into disposable and reusable injection pens. Both disposable and reusable forms of diabetes injection pens are nearly equally used across patients worldwide. However, it is observed that reusable pens are more preferred in developed markets. It is anticipated that the same trend will continue through the forecast period, with higher preference for disposable injection forms being more preferred in developing economies.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
This report categorizes the global diabetes injection pens market in terms of Diabetes type, product type, form and geographical distribution. Based on diabetes type, the global diabetes injection pens market is categorized into type I and type II diabetes. Insulin pens and insulin pen needles are the major product types considered in this study. Furthermore, disposable and reusable forms of diabetes injection pens are also studies in this report. Market size and forecast for each mentioned segment for the period 2020-2030 is presented in the report along with respective CAGRs for the forecast duration 2022-2030.
The market size and forecast of each considered geographical market is presented for the period 2020-2030 along with CAGRs for the forecast period 2022-2030 in this study and are further cross-sectional presented in terms of diabetes type, product type, form, and constituent region/country level markets.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global diabetes injection pens market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the diabetes injection pens market. The key players profiled in this report are AstraZeneca plc, Becton, Dickinson and Company, Biocon Ltd., Eli Lilly and Company, Jiangsu Delfu Co., Novo Nordisk A/S, Owen Mumford Ltd. and Wockhardt Ltd.
Injection pens are observed to be administered in both type I and type II patients. Between these patient groups, type II diabetes acquires the larger revenue share due to large patient population belonging to this condition. In addition, since type II diabetes majorly occurs in adult individuals, rational insulin administration through injection pens is highly prevalent. However, increasing patient base of children suffering with type II diabetes presents lucrative penetration opportunity to the diabetes injection pens manufacturers. Based on injection forms, this market is categorized into disposable and reusable injection pens. Both disposable and reusable forms of diabetes injection pens are nearly equally used across patients worldwide. However, it is observed that reusable pens are more preferred in developed markets. It is anticipated that the same trend will continue through the forecast period, with higher preference for disposable injection forms being more preferred in developing economies.
Geographically, the global diabetes injection pens market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Among the considered regional markets, North America and Europe together occupy the largest revenue share of the global diabetes injection pens market. In North America and globally, the United States captures the largest revenue share. The dominance of United States is attributed to large diabetic population, better reimbursement system and healthcare awareness about treatment and management of diabetes. The Europe market, however, is observed to be saturated and will undergo average growth rate. Furthermore, Asia Pacific is anticipated to be the fastest progressing regional market for diabetes injection pens. Growing awareness and increased ability of patients to pay for advanced medicine are the key driving factors for Asia Pacific diabetes injection pens market.Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Diabetes Injection Pens market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Diabetes Injection Pens market and their expected impact during the forecast period.
Market Segmentation
Indication
- Type I Diabetes
- Type II Diabetes
Product
- Insulin Pens
- Insulin Pen Needles
Form
- Disposable
- Reusable
Key Questions Answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Diabetes Injection Pens market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Diabetes Injection Pens market?
- Which is the largest regional market for Diabetes Injection Pens market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Diabetes Injection Pens market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Diabetes Injection Pens market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Diabetes Injection Pens Market
2.2. Global Diabetes Injection Pens Market, By Indication, 2021 (US$ Million)
2.3. Global Diabetes Injection Pens Market, By Product, 2021 (US$ Million)
2.4. Global Diabetes Injection Pens Market, By Form, 2021 (US$ Million)
2.5. Global Diabetes Injection Pens Market, By Geography, 2021 (US$ Million)
2.6. Impact of Covid 19
2.7. Attractive Investment Proposition by Geography, 2021
2.8. Competitive Analysis
2.8.1. Market Positioning of Key Diabetes Injection Pens Market Vendors
2.8.2. Strategies Adopted by Diabetes Injection Pens Market Vendors
2.8.3. Key Industry Strategies
3. Diabetes Injection Pens Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Diabetes Injection Pens Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
4. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Type I Diabetes
4.3.2. Type II Diabetes
5. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Insulin Pens
5.3.2. Insulin Pen Needles
6. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Disposable
6.3.2. Reusable7. North America Diabetes Injection Pens Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
7.3. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
7.4. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
7.5.Diabetes Injection Pens Market: By Region, 2020-2030, USD (Million)
7.5.1.North America
7.5.1.1. U.S.
7.5.1.2. Canada
7.5.1.3. Rest of North America
8. UK and European Union Diabetes Injection Pens Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
8.3. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
8.4. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
8.5.Diabetes Injection Pens Market: By Region, 2020-2030, USD (Million)
8.5.1.UK and European Union
8.5.1.1. UK
8.5.1.2. Germany
8.5.1.3. Spain
8.5.1.4. Italy
8.5.1.5. France
8.5.1.6. Rest of Europe
9. Asia Pacific Diabetes Injection Pens Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
9.3. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
9.4. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
9.5.Diabetes Injection Pens Market: By Region, 2020-2030, USD (Million)
9.5.1.Asia Pacific
9.5.1.1. China
9.5.1.2. Japan
9.5.1.3. India
9.5.1.4. Australia
9.5.1.5. South Korea
9.5.1.6. Rest of Asia Pacific
10. Latin America Diabetes Injection Pens Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
10.3. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
10.4. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
10.5.Diabetes Injection Pens Market: By Region, 2020-2030, USD (Million)
10.5.1.Latin America
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
11. Middle East and Africa Diabetes Injection Pens Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
11.3. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
11.4. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
11.5.Diabetes Injection Pens Market: By Region, 2020-2030, USD (Million)
11.5.1.Middle East and Africa
11.5.1.1. GCC
11.5.1.2. Africa
11.5.1.3. Rest of Middle East and Africa
12. Company Profile
12.1. AstraZeneca plc
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Becton, Dickinson and Company
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Biocon Ltd.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Eli Lilly and Company
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Jiangsu Delfu Co.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Novo Nordisk A/S
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Owen Mumford Ltd.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Wockhardt Ltd.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Other Notable Players
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
List of Figures
Figure 1. Global Diabetes Injection Pens Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Diabetes Injection Pens Market: Quality Assurance
Figure 5 Global Diabetes Injection Pens Market, By Indication, 2021
Figure 6 Global Diabetes Injection Pens Market, By Product, 2021
Figure 7 Global Diabetes Injection Pens Market, By Form, 2021
Figure 8 Global Diabetes Injection Pens Market, By Geography, 2021
Figure 9 Global Diabetes Injection Pens Market, By Indication, 2021 Vs 2030, %
Figure 10 Global Diabetes Injection Pens Market, By Product, 2021 Vs 2030, %
Figure 11 Global Diabetes Injection Pens Market, By Form, 2021 Vs 2030, %
Figure 12 U.S. Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 13 Canada Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 14 Rest of North America Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 15 UK Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 16 Germany Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 17 Spain Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 18 Italy Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 19 France Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 20 Rest of Europe Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 21 China Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 22 Japan Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 23 India Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 24 Australia Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 25 South Korea Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 26 Rest of Asia Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 27 Brazil Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 28 Mexico Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 29 Rest of Latin America Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 30 GCC Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 31 Africa Diabetes Injection Pens Market (US Million), 2020 - 2030
Figure 32 Rest of Middle East and Africa Diabetes Injection Pens Market (US Million), 2020 - 2030
List of Tables
Table 1 Global Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
Table 2 Global Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
Table 3 Global Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
Table 4 North America Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
Table 5 North America Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
Table 6 North America Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
Table 7 UK and European Union Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
Table 8 UK and European Union Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
Table 9 UK and European Union Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
Table 10 Asia Pacific Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
Table 11 Asia Pacific Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
Table 12 Asia Pacific Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
Table 13 Latin America Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
Table 14 Latin America Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
Table 15 Latin America Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
Table 16 Middle East and Africa Diabetes Injection Pens Market By Indication, 2020-2030, USD (Million)
Table 17 Middle East and Africa Diabetes Injection Pens Market By Product, 2020-2030, USD (Million)
Table 18 Middle East and Africa Diabetes Injection Pens Market By Form, 2020-2030, USD (Million)
Companies Mentioned
- AstraZeneca plc
- Becton
- Dickinson and Company
- Biocon Ltd.
- Eli Lilly and Company
- Jiangsu Delfu Co.
- Novo Nordisk A/S
- Owen Mumford Ltd.
- Wockhardt Ltd.
